NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
13/11/2025
Voltar para busca
Dado oficial do USPTO
NURALOGIX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
31
Atualização mais recente
14/11/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
9, 42
Data de depósito
13/11/2017
Data de registro
31/12/2019
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
13/11/2025
Última transação
14/11/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
702
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
3
Tipo de titular
03
Localização do titular
Toronto, Ontario, CA
Examinador
MUNN LEWIS,LAKEISHA S
Localização atual
Historical data usage
Descrição da marca
The mark consists of an image of six interconnected dots inside of hexagon appearing to the left side of the word "nuralogix" in stylized font.
Titulares e representantes
Titulares
N. C. (pessoa física)
Representantes
Rupam Bhar Calderon Safran & Wright PC
Classificação técnica
Classes Nice
Classe 9Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Computer software for communicating with computer users and medical practitioners about healthcare; Computer software for image processing; computer software for medical imaging; computer software for processing digital images for detectingmeasuringevaluating and identifying emotionsentimentdeceptionemotional expressionsemotional reactionsfacial expressionsfacial expression signalsfacial blood flowphysiological signalsphysiological expressionsfor use in medical diagnosticsmedical imagingbehavioural analysismarket researchmarket opinion pollingconducting business and market research surveyscollection of market research informationproduct research and developmentmarketing analysisanalysis of advertising responseborderlaw enforcementimmigrationconsular and security screening; security screening device featuring cameras for screening personsfor detection of deception for use in borderlaw enforcementimmigrationconsular and security screening of persons; device featuring cameras for detecting sentiment and emotional reactions to productsbrandsadvertising of othersincluding to product display racks; computer software for enabling an on-line focus group for evaluating the goods and services of others and behavioural anaylsis; computer software for health care and medical diagnosticsfor performing internet-enabled remote healthcare and medical diagnostics
Classe 42
Providing online non-downloadable software as a service (SaaS) for enabling others to access and use software for image processing; providing online non-downloadable software as a service (SaaS) for enabling others to access and use software for medical imaging; providing online non-downloadable software as a service (SaaS) for enabling others to access and use software for communicating with computer users and medical practitioners about healthcare; providing online non-downloadable software for enabling others to access and use software for processing digital images for detectingmeasuringevaluating and identifying emotionsentimentdeceptionemotional expressionsemotional reactionsfacial expressionsfacial expression signalsfacial blood flowphysiological signalsphysiological expressionsfor use in medical diagnosticsmedical imagingbehavioural analysismarket researchmarket opinion pollingconducting business and market research surveyscollection of market research informationproduct research and developmentmarketing analysisanalysis of advertising responseborderlaw enforcementimmigrationconsular and security screening; providing online non-downloadable software for enabling others to access and use software for enabling an on-line focus group for the goods and services of others; providing software as a service (SaaS) for enabling others to access and use software for health care and medical diagnosticsfor performing internet-enabled remote medical diagnostics; computer software consulting; product design consulting services
Publicações
Histórico de despachos e eventos da marca no USPTO.
31 publicações encontradas
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
13/11/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
13/11/2025
E815
TEAS SECTION 8 & 15 RECEIVED
23/07/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
31/12/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
31/12/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15/10/2019
PUBO
PUBLISHED FOR OPPOSITION
15/10/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
25/09/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/09/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/08/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/08/2019
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
09/08/2019
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
11/02/2019
GNSI
INQUIRY TO SUSPENSION E-MAILED
11/02/2019
CNSI
SUSPENSION INQUIRY WRITTEN
11/02/2019
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
09/01/2019
ALIE
ASSIGNED TO LIE
09/01/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
11/05/2018
GNSL
LETTER OF SUSPENSION E-MAILED
11/05/2018
CNSL
SUSPENSION LETTER WRITTEN
11/05/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/04/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/04/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
23/04/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
19/01/2018
GNRT
NON-FINAL ACTION E-MAILED
19/01/2018
CNRT
NON-FINAL ACTION WRITTEN
19/01/2018
DOCK
ASSIGNED TO EXAMINER
16/01/2018
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
25/11/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
24/11/2017
NWAP
NEW APPLICATION ENTERED
16/11/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NURALOGIX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.